Viewing StudyNCT00115219



Ignite Creation Date: 2024-05-05 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00115219
Status: COMPLETED
Last Update Posted: 2013-05-30
First Post: 2005-06-21

Brief Title: Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly BIW in Rheumatoid Arthritis RA Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly QW
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Rheumatoid Arthritis
Keywords:
Name View
Rheumatoid Arthritis RA View
Rheumatoid Arthritis RA View
Enbrel etanercept View
Clinical Trials Amgen View
Immunex Methotrexate MTX View